Moreover, Hras codon 61 mutations, which were found at high frequencies in mammary adenocarcinomas induced by oral DMBA treatment of the heterozygous BALB/c-Trp53 knockout mice, did not appear in the list of 142 SNVs. This evidence concerns the gene HRAS and breast adenocarcinoma.